Follow the 프로티나 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 프로티나 has recorded 23 insider filings. The latest transaction was reported on 30 December 2025 (Sale). Among the most active insiders: LB인베스트먼트. Every trade is openly available.
23
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
4 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Protinah is a company operating in the health and pharmaceutical sector, listed on the XKRX. It specializes in the development of innovative pharmaceutical products.